Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Small+Cell+Lung+Carcinoma%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22Small+Cell+Lung+Carcinoma%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22Small+Cell+Lung+Carcinoma%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (284)
1
Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC) : Combined immunotherapy with the vaccine preparation NGcGM3/VSSP and the monoclonal antibody nimotuzumab, in patients with advanced non-small cell lung cancer (NSCLC)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Predictor of response with CIMAvax EGF© in NSCLC Phase III : Survival of patients with advanced Non Small Cells Lung Cancer and EGF concentration in sera highest than 870 pg/mL that receive CIMAvax EGF© as maintenance therapy.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT) : Phase II-III clinical trial, controlled, randomized, in parallel, adaptive design in two stages, compared, in patients with inoperable stage III epidermoid histology NSCLC, treated with concurrent CT-RT plus Nimotuzumab vs concurrent CT-RT. - Nimotuzumab in NSCLC concomitant with CRT
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Anti-idiotype 1E10 vaccine in advanced non- small cell lung (NSCLC) patients : Phase II study: Active specific immunotherapy with the 1e10 anti idiotype vaccine in the treatment of patients with advanced non small cell lung Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Anti-idiotype 1E10 vaccine in the treatment of patients with small cell lung (SCLC) patients : Active specific immunotherapy with the 1E10 anti-idiotype vaccine in the treatment of patients with small-cell lung cancer.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
CIMAvax-EGF in patients at high risk of lung cancer : Phase I study in patients at high risk of lung cancer and early-stage lung cancer survivors treated with the therapeutic vaccine CIMAvax®
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Vaxira as adjuvant treatment for non-small cell lung cancer : Open randomized controlled clinical trial in patients with non-small cell lung cancer, stage IB, II and IIIA, treated or not with VAXIRA®, after surgery and adjuvant cisplatin-based chemotherapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
CIMAvax-EGF vaccine Predictor Phase IV : Security of CIMAvax-EGF® vaccine for the treatment of patients with NSCLC in advanced stages. Effectiveness exploration according to baseline concentrations of EGF. phase IV
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Gastrointestinal and lung cancer, effects of the fish oil intake on nutritional status, quality of life and imunnometabolic outcomes : Gastrointestinal and lung cancer, effects of the fish oil intake on nutritional status, quality of life and imunnometabolic outcomes
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory : Identification of potential predictors and surrogates for the selection of patients who may benefit from the use of Racotumomab, as switch maintenance therapy, in patients with non-small cell lung cancer, stages IIIA, IIIB and IV.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[29]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
284
Aufsätze
284
E-Artikel
284
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
284
610
252
Study Type: Interventional
152
Recruitment Status: Not yet recruiting
92
Phase: Phase 3
44
Recruitment Status: Authorised-recruitment may ...
40
Recruitment Status: Recruiting
28
Study Type: Observational
26
Phase: Phase 2
24
Recruitment Status: Completed
22
Medical Condition: Non-Small Cell Lung Carcinom...
14
Medical Condition: Non-small cell lung carcinom...
14
Recruitment Status: Complete: follow-up complete
10
Medical Condition: Non-small-cell lung carcinoma
10
Phase: Phase 1
8
Phase: Phase 1/Phase 2
6
Medical Condition: Non-small cell lung carcinoma
6
Medical Condition: Stage IB-IIIA Non-small Cell...
6
Medical Condition: late stage (IIIb/IV) Non-sma...
4
Medical Condition: Advanced non small cell lung...
4
Medical Condition: Lung cancer;Carcinoma, Non-S...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
174
2020-
110
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
270
Englisch
14
Unbestimmt
Haven't found what you're looking for?
Wird geladen...